| Date | TitleTitle | |||
|---|---|---|---|---|
| 06/08/26 | 07:00:05 | 6 Aug 2026 | Notice of acceptance of patent in Australia | |
| 20/07/26 | 09:00:00 | 20 Jul 2026 | Grant of options | |
| 01/07/26 | 16:45:25 | 1 Jul 2026 | Holding(s) in Company | |
| 30/06/26 | 17:00:00 | 30 Jun 2026 | Total Voting Rights | |
| 22/06/26 | 07:00:11 | 22 Jun 2026 | Notice of allowance of patent in Canada | |
| 15/06/26 | 07:00:12 | 15 Jun 2026 | Update on grant-funded DR5 project | |
| 02/06/26 | 07:00:03 | 2 Jun 2026 | Exercise of options and total voting rights | |
| 11/05/26 | 15:06:28 | 11 May 2026 | Holding(s) in Company | |
| 11/05/26 | 11:05:22 | 11 May 2026 | Grant of patent in Japan | |
| 05/05/26 | 07:00:10 | 5 May 2026 | Year-end trading statement | |
| 30/03/26 | 07:00:09 | 30 Mar 2026 | Antibody IP transfer agreement | |
| 17/02/26 | 11:42:46 | 17 Feb 2026 | Director/PDMR Shareholding | |
| 04/02/26 | 15:27:58 | 4 Feb 2026 | Holding(s) in Company | |
| 02/02/26 | 11:33:55 | 2 Feb 2026 | Holding(s) in Company | |
| 30/01/26 | 17:00:01 | 30 Jan 2026 | Total Voting Rights | |
| 27/01/26 | 07:05:00 | 27 Jan 2026 | Issue of Director Shares | |
| 27/01/26 | 07:00:04 | 27 Jan 2026 | Placing and Subscription to raise approx £1.4m | |
| 19/12/25 | 07:00:08 | 19 Dec 2025 | Update on negotiations with NCI regarding OptiMAL | |
| 16/12/25 | 11:04:41 | 16 Dec 2025 | Launch of OptiMAL platform | |
| 11/12/25 | 07:00:09 | 11 Dec 2025 | Mammalian Display video | |
| 25/11/25 | 12:11:25 | 25 Nov 2025 | Holding(s) in Company | |
| 24/11/25 | 07:00:07 | 24 Nov 2025 | Half-year Financial Report | |
| 21/11/25 | 07:00:13 | 21 Nov 2025 | Notice of Results | |
| 13/11/25 | 07:00:14 | 13 Nov 2025 | OptiMAL Library video | |
| 03/11/25 | 07:00:07 | 3 Nov 2025 | OptiMAL® R&D Update | |
| 27/10/25 | 15:38:51 | 27 Oct 2025 | Holding(s) in Company | |
| 16/10/25 | 13:31:11 | 16 Oct 2025 | Result of AGM | |
| 16/10/25 | 07:00:06 | 16 Oct 2025 | AGM statement and H1 trading update | |
| 08/10/25 | 07:00:03 | 8 Oct 2025 | Contract win | |
| 19/09/25 | 12:58:05 | 19 Sept 2025 | Posting of Annual Report & Notice of AGM | |
| 17/09/25 | 07:00:07 | 17 Sept 2025 | OptiMAL R&D Update | |
| 08/09/25 | 07:00:11 | 8 Sept 2025 | Belfast investor presentation | |
| 04/09/25 | 07:00:14 | 4 Sept 2025 | Final Results | |
| 28/08/25 | 07:00:08 | 28 Aug 2025 | Contract Win | |
| 27/08/25 | 07:00:03 | 27 Aug 2025 | Contract wins with existing client | |
| 26/08/25 | 07:00:14 | 26 Aug 2025 | Investor presentations | |
| 05/08/25 | 07:00:17 | 5 Aug 2025 | Grant of U.S. Patent for OptiMAL | |
| 24/07/25 | 10:56:04 | 24 Jul 2025 | Issue Notification: US Patent Update | |
| 11/07/25 | 07:00:08 | 11 Jul 2025 | Director/PDMR Shareholding | |
| 02/06/25 | 07:00:08 | 2 Jun 2025 | Total Voting Rights | |
| 22/05/25 | 14:33:29 | 22 May 2025 | Update on U.S. Patent for OptiMAL® | |
| 08/05/25 | 07:00:12 | 8 May 2025 | Investor presentation | |
| 07/05/25 | 07:00:10 | 7 May 2025 | Issue of shares to non-executive directors | |
| 06/05/25 | 10:53:50 | 6 May 2025 | Director/PDMR Shareholding | |
| 06/05/25 | 10:38:35 | 6 May 2025 | Holding(s) in Company | |
| 06/05/25 | 07:00:13 | 6 May 2025 | Trading update | |
| 30/04/25 | 17:00:01 | 30 Apr 2025 | Total Voting Rights | |
| 24/04/25 | 07:00:08 | 24 Apr 2025 | Approval of grant funding | |
| 11/04/25 | 10:40:05 | 11 Apr 2025 | Holding(s) in Company | |
| 10/04/25 | 12:47:06 | 10 Apr 2025 | Holding(s) in Company |
| Date | TitleTitle | |||
|---|---|---|---|---|
| 06/08/26 | 07:00:05 | 6 Aug 2026 | Notice of acceptance of patent in Australia | |
| 20/07/26 | 09:00:00 | 20 Jul 2026 | Grant of options | |
| 01/07/26 | 16:45:25 | 1 Jul 2026 | Holding(s) in Company | |
| 30/06/26 | 17:00:00 | 30 Jun 2026 | Total Voting Rights | |
| 22/06/26 | 07:00:11 | 22 Jun 2026 | Notice of allowance of patent in Canada | |
| 15/06/26 | 07:00:12 | 15 Jun 2026 | Update on grant-funded DR5 project | |
| 02/06/26 | 07:00:03 | 2 Jun 2026 | Exercise of options and total voting rights | |
| 11/05/26 | 15:06:28 | 11 May 2026 | Holding(s) in Company | |
| 11/05/26 | 11:05:22 | 11 May 2026 | Grant of patent in Japan | |
| 05/05/26 | 07:00:10 | 5 May 2026 | Year-end trading statement | |
| 30/03/26 | 07:00:09 | 30 Mar 2026 | Antibody IP transfer agreement | |
| 17/02/26 | 11:42:46 | 17 Feb 2026 | Director/PDMR Shareholding | |
| 04/02/26 | 15:27:58 | 4 Feb 2026 | Holding(s) in Company | |
| 02/02/26 | 11:33:55 | 2 Feb 2026 | Holding(s) in Company | |
| 30/01/26 | 17:00:01 | 30 Jan 2026 | Total Voting Rights | |
| 27/01/26 | 07:05:00 | 27 Jan 2026 | Issue of Director Shares | |
| 27/01/26 | 07:00:04 | 27 Jan 2026 | Placing and Subscription to raise approx £1.4m | |
| 19/12/25 | 07:00:08 | 19 Dec 2025 | Update on negotiations with NCI regarding OptiMAL | |
| 16/12/25 | 11:04:41 | 16 Dec 2025 | Launch of OptiMAL platform | |
| 11/12/25 | 07:00:09 | 11 Dec 2025 | Mammalian Display video | |
| 25/11/25 | 12:11:25 | 25 Nov 2025 | Holding(s) in Company | |
| 24/11/25 | 07:00:07 | 24 Nov 2025 | Half-year Financial Report | |
| 21/11/25 | 07:00:13 | 21 Nov 2025 | Notice of Results | |
| 13/11/25 | 07:00:14 | 13 Nov 2025 | OptiMAL Library video | |
| 03/11/25 | 07:00:07 | 3 Nov 2025 | OptiMAL® R&D Update | |
| 27/10/25 | 15:38:51 | 27 Oct 2025 | Holding(s) in Company | |
| 16/10/25 | 13:31:11 | 16 Oct 2025 | Result of AGM | |
| 16/10/25 | 07:00:06 | 16 Oct 2025 | AGM statement and H1 trading update | |
| 08/10/25 | 07:00:03 | 8 Oct 2025 | Contract win | |
| 19/09/25 | 12:58:05 | 19 Sept 2025 | Posting of Annual Report & Notice of AGM | |
| 17/09/25 | 07:00:07 | 17 Sept 2025 | OptiMAL R&D Update | |
| 08/09/25 | 07:00:11 | 8 Sept 2025 | Belfast investor presentation | |
| 04/09/25 | 07:00:14 | 4 Sept 2025 | Final Results | |
| 28/08/25 | 07:00:08 | 28 Aug 2025 | Contract Win | |
| 27/08/25 | 07:00:03 | 27 Aug 2025 | Contract wins with existing client | |
| 26/08/25 | 07:00:14 | 26 Aug 2025 | Investor presentations | |
| 05/08/25 | 07:00:17 | 5 Aug 2025 | Grant of U.S. Patent for OptiMAL | |
| 24/07/25 | 10:56:04 | 24 Jul 2025 | Issue Notification: US Patent Update | |
| 11/07/25 | 07:00:08 | 11 Jul 2025 | Director/PDMR Shareholding | |
| 02/06/25 | 07:00:08 | 2 Jun 2025 | Total Voting Rights | |
| 22/05/25 | 14:33:29 | 22 May 2025 | Update on U.S. Patent for OptiMAL® | |
| 08/05/25 | 07:00:12 | 8 May 2025 | Investor presentation | |
| 07/05/25 | 07:00:10 | 7 May 2025 | Issue of shares to non-executive directors | |
| 06/05/25 | 10:53:50 | 6 May 2025 | Director/PDMR Shareholding | |
| 06/05/25 | 10:38:35 | 6 May 2025 | Holding(s) in Company | |
| 06/05/25 | 07:00:13 | 6 May 2025 | Trading update | |
| 30/04/25 | 17:00:01 | 30 Apr 2025 | Total Voting Rights | |
| 24/04/25 | 07:00:08 | 24 Apr 2025 | Approval of grant funding | |
| 11/04/25 | 10:40:05 | 11 Apr 2025 | Holding(s) in Company | |
| 10/04/25 | 12:47:06 | 10 Apr 2025 | Holding(s) in Company |